10-Q Filing
Filing Information
| Form Type | 10-Q |
| Accession Number | 0001558370-18-003777 |
| Period End Date | 20180331 |
| Filing Date | 20180502 |
| Fiscal Year | 2018 |
| Fiscal Period | Q1 |
| XBRL Instance | cvs-20180331.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
83 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Preferred Stock, par value (in dollars per share) |
PreferredStockParOrStatedValuePerShare
|
$0.01 | USD | Point-in-time |
| Preferred Stock, par value (in dollars per share) |
PreferredStockParOrStatedValuePerShare
|
$0.01 | USD | Point-in-time |
| Preferred Stock, shares authorized (in shares) |
PreferredStockSharesAuthorized
|
100,000.00 | shares | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$1.70B | USD | Point-in-time |
| Preferred Stock, shares authorized (in shares) |
PreferredStockSharesAuthorized
|
100,000.00 | shares | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$42.02B | USD | Point-in-time |
| Short-term investments |
ShortTermInvestments
|
$119.00M | USD | Point-in-time |
| Preferred Stock, shares issued (in shares) |
PreferredStockSharesIssued
|
0.00 | shares | Point-in-time |
| Short-term investments |
ShortTermInvestments
|
$111.00M | USD | Point-in-time |
| Preferred Stock, shares issued (in shares) |
PreferredStockSharesIssued
|
0.00 | shares | Point-in-time |
| Accounts receivable, net |
AccountsReceivableNetCurrent
|
$13.96B | USD | Point-in-time |
| Preferred Stock, shares outstanding (in shares) |
PreferredStockSharesOutstanding
|
0.00 | shares | Point-in-time |
| Accounts receivable, net |
AccountsReceivableNetCurrent
|
$13.18B | USD | Point-in-time |
| Preferred Stock, shares outstanding (in shares) |
PreferredStockSharesOutstanding
|
0.00 | shares | Point-in-time |
| Common Stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.01 | USD | Point-in-time |
| Inventories |
InventoryNet
|
$14.82B | USD | Point-in-time |
| Common Stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.01 | USD | Point-in-time |
| Inventories |
InventoryNet
|
$15.30B | USD | Point-in-time |
| Common Stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
3.20B | shares | Point-in-time |
| Other current assets |
OtherAssetsCurrent
|
$945.00M | USD | Point-in-time |
| Other current assets |
OtherAssetsCurrent
|
$868.00M | USD | Point-in-time |
| Common Stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
3.20B | shares | Point-in-time |
| Total current assets |
AssetsCurrent
|
$31.23B | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$71.80B | USD | Point-in-time |
| Common Stock, shares issued (in shares) |
CommonStockSharesIssued
|
1.71B | shares | Point-in-time |
| Common Stock, shares issued (in shares) |
CommonStockSharesIssued
|
1.71B | shares | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$10.14B | USD | Point-in-time |
| Common Stock, shares outstanding (in shares) |
CommonStockSharesOutstanding
|
1.02B | shares | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$10.29B | USD | Point-in-time |
| Common Stock, shares outstanding (in shares) |
CommonStockSharesOutstanding
|
1.01B | shares | Point-in-time |
| Goodwill |
Goodwill
|
$38.45B | USD | Point-in-time |
| Goodwill |
Goodwill
|
$38.12B | USD | Point-in-time |
| Treasury Stock, shares (in shares) |
TreasuryStockShares
|
697.00M | shares | Point-in-time |
| Treasury Stock, shares (in shares) |
TreasuryStockShares
|
697.00M | shares | Point-in-time |
| Shares held in trust: 1 share at September 30, 2017 and December 31, 2016 (in shares) |
CommonStockSharesHeldInEmployeeTrustShares
|
1.00M | shares | Point-in-time |
| Shares held in trust: 1 share at September 30, 2017 and December 31, 2016 (in shares) |
CommonStockSharesHeldInEmployeeTrustShares
|
1.00M | shares | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$13.63B | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$13.39B | USD | Point-in-time |
| Other assets |
OtherAssetsNoncurrent
|
$1.69B | USD | Point-in-time |
| Other assets |
OtherAssetsNoncurrent
|
$1.53B | USD | Point-in-time |
| Total assets |
Assets
|
$95.13B | USD | Point-in-time |
| Total assets |
Assets
|
$135.14B | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$8.86B | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$7.74B | USD | Point-in-time |
| Claims and discounts payable |
ClaimsAndDiscountsPayable
|
$10.36B | USD | Point-in-time |
| Claims and discounts payable |
ClaimsAndDiscountsPayable
|
$11.24B | USD | Point-in-time |
| Accrued expenses |
AccruedLiabilitiesCurrent
|
$7.72B | USD | Point-in-time |
| Accrued expenses |
AccruedLiabilitiesCurrent
|
$6.61B | USD | Point-in-time |
| Short-term debt |
ShortTermBorrowings
|
$1.28B | USD | Point-in-time |
| Current portion of long-term debt |
LongTermDebtCurrent
|
$3.54B | USD | Point-in-time |
| Current portion of long-term debt |
LongTermDebtCurrent
|
$3.54B | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$30.65B | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$30.25B | USD | Point-in-time |
| Long-term debt |
LongTermDebtNoncurrent
|
$22.18B | USD | Point-in-time |
| Long-term debt |
LongTermDebtNoncurrent
|
$61.55B | USD | Point-in-time |
| Deferred income taxes |
DeferredTaxLiabilitiesNoncurrent
|
$3.06B | USD | Point-in-time |
| Deferred income taxes |
DeferredTaxLiabilitiesNoncurrent
|
$3.00B | USD | Point-in-time |
| Other long-term liabilities |
OtherLiabilitiesNoncurrent
|
$1.61B | USD | Point-in-time |
| Other long-term liabilities |
OtherLiabilitiesNoncurrent
|
$1.60B | USD | Point-in-time |
| Total Liabilities |
Liabilities
|
$96.46B | USD | Point-in-time |
| Total Liabilities |
Liabilities
|
$57.44B | USD | Point-in-time |
| Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding |
PreferredStockValue
|
- | USD | Point-in-time |
| Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding |
PreferredStockValue
|
- | USD | Point-in-time |
| Common stock, par value $0.01: 3,200 shares authorized; 1,714 shares issued and 1,016 shares outstanding at March 31, 2018 and 1,712 shares issued and 1,014 shares outstanding at December 31, 2017 |
CommonStockValue
|
$17.00M | USD | Point-in-time |
| Common stock, par value $0.01: 3,200 shares authorized; 1,714 shares issued and 1,016 shares outstanding at March 31, 2018 and 1,712 shares issued and 1,014 shares outstanding at December 31, 2017 |
CommonStockValue
|
$17.00M | USD | Point-in-time |
| Capital surplus |
AdditionalPaidInCapital
|
$32.19B | USD | Point-in-time |
| Capital surplus |
AdditionalPaidInCapital
|
$32.08B | USD | Point-in-time |
| Treasury stock, at cost: 697 shares at March 31, 2018 and December 31, 2017 |
TreasuryStockValue
|
$37.72B | USD | Point-in-time |
| Treasury stock, at cost: 697 shares at March 31, 2018 and December 31, 2017 |
TreasuryStockValue
|
$37.77B | USD | Point-in-time |
| Shares held in trust: 1 share at March 31, 2018 and December 31, 2017 |
CommonStockSharesHeldInEmployeeTrust
|
$31.00M | USD | Point-in-time |
| Shares held in trust: 1 share at March 31, 2018 and December 31, 2017 |
CommonStockSharesHeldInEmployeeTrust
|
$31.00M | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$43.56B | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$44.04B | USD | Point-in-time |
| Accumulated other comprehensive income (loss) |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$172.00M | USD | Point-in-time |
| Accumulated other comprehensive income (loss) |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-165.00M | USD | Point-in-time |
| Total CVS Health shareholders equity |
StockholdersEquity
|
$38.67B | USD | Point-in-time |
| Total CVS Health shareholders equity |
StockholdersEquity
|
$37.69B | USD | Point-in-time |
| Noncontrolling interest |
MinorityInterest
|
$4.00M | USD | Point-in-time |
| Noncontrolling interest |
MinorityInterest
|
$4.00M | USD | Point-in-time |
| Total shareholders equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$37.70B | USD | Point-in-time |
| Total shareholders equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$38.68B | USD | Point-in-time |
| Total liabilities and shareholders equity |
LiabilitiesAndStockholdersEquity
|
$95.13B | USD | Point-in-time |
| Total liabilities and shareholders equity |
LiabilitiesAndStockholdersEquity
|
$135.14B | USD | Point-in-time |
Income Statement
42 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net revenues |
Revenues
|
$44.51B | USD | 1 Quarter |
| Net revenues |
Revenues
|
$45.69B | USD | 1 Quarter |
| Cost of Goods and Services Sold |
CostOfGoodsAndServicesSold
|
$38.83B | USD | 1 Quarter |
| Cost of Goods and Services Sold |
CostOfGoodsAndServicesSold
|
$37.94B | USD | 1 Quarter |
| Gross profit |
GrossProfit
|
$6.86B | USD | 1 Quarter |
| Gross profit |
GrossProfit
|
$6.57B | USD | 1 Quarter |
| Operating expenses |
OperatingExpenses
|
$4.78B | USD | 1 Quarter |
| Operating expenses |
OperatingExpenses
|
$4.91B | USD | 1 Quarter |
| Operating profit |
OperatingIncomeLoss
|
$1.79B | USD | 1 Quarter |
| Operating profit |
OperatingIncomeLoss
|
$1.95B | USD | 1 Quarter |
| Interest expense, net |
InterestIncomeExpenseNet
|
$-473.00M | USD | 1 Quarter |
| Interest expense, net |
InterestIncomeExpenseNet
|
$-252.00M | USD | 1 Quarter |
| Other expense |
OtherNonoperatingExpense
|
$3.00M | USD | 1 Quarter |
| Other expense |
OtherNonoperatingExpense
|
$7.00M | USD | 1 Quarter |
| Income before income tax provision |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$1.53B | USD | 1 Quarter |
| Income before income tax provision |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$1.47B | USD | 1 Quarter |
| Income tax provision |
IncomeTaxExpenseBenefit
|
$472.00M | USD | 1 Quarter |
| Income tax provision |
IncomeTaxExpenseBenefit
|
$572.00M | USD | 1 Quarter |
| Income from continuing operations |
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
$998.00M | USD | 1 Quarter |
| Income from continuing operations |
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
$962.00M | USD | 1 Quarter |
| Loss from discontinued operations, net of tax |
IncomeLossFromDiscontinuedOperationsNetOfTax
|
$-9.00M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$998.00M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$953.00M | USD | 1 Quarter |
| Net income attributable to noncontrolling interest |
NetIncomeLossAttributableToNoncontrollingInterest
|
$1.00M | USD | 1 Quarter |
| Net income attributable to CVS Health |
NetIncomeLoss
|
$952.00M | USD | 1 Quarter |
| Net income attributable to CVS Health |
NetIncomeLoss
|
$998.00M | USD | 1 Quarter |
| Income from continuing operations attributable to CVS Health (in dollars per share) |
IncomeLossFromContinuingOperationsPerBasicShare
|
$0.98 | USD | 1 Quarter |
| Income from continuing operations attributable to CVS Health (in dollars per share) |
IncomeLossFromContinuingOperationsPerBasicShare
|
$0.93 | USD | 1 Quarter |
| Loss from discontinued operations attributable to CVS Health (in dollars per share) |
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
$-0.01 | USD | 1 Quarter |
| Net income attributable to CVS Health (in dollars per share) |
EarningsPerShareBasic
|
$0.98 | USD | 1 Quarter |
| Net income attributable to CVS Health (in dollars per share) |
EarningsPerShareBasic
|
$0.92 | USD | 1 Quarter |
| Weighted average shares outstanding (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
1.02B | shares | 1 Quarter |
| Weighted average shares outstanding (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
1.03B | shares | 1 Quarter |
| Income from continuing operations attributable to CVS Health (in dollars per share) |
IncomeLossFromContinuingOperationsPerDilutedShare
|
$0.98 | USD | 1 Quarter |
| Income from continuing operations attributable to CVS Health (in dollars per share) |
IncomeLossFromContinuingOperationsPerDilutedShare
|
$0.92 | USD | 1 Quarter |
| Loss from discontinued operations attributable to CVS Health (in dollars per share) |
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
$-0.01 | USD | 1 Quarter |
| Net income attributable to CVS Health (in dollars per share) |
EarningsPerShareDiluted
|
$0.92 | USD | 1 Quarter |
| Net income attributable to CVS Health (in dollars per share) |
EarningsPerShareDiluted
|
$0.98 | USD | 1 Quarter |
| Weighted average shares outstanding (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
1.03B | shares | 1 Quarter |
| Weighted average shares outstanding (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
1.02B | shares | 1 Quarter |
| Dividends declared per share (in dollars per share) |
CommonStockDividendsPerShareDeclared
|
$0.50 | USD | 1 Quarter |
| Dividends declared per share (in dollars per share) |
CommonStockDividendsPerShareDeclared
|
$0.50 | USD | 1 Quarter |
Cash Flow Statement
75 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Cash receipts from customers |
ProceedsFromCustomers
|
$43.91B | USD | 1 Quarter |
| Cash receipts from customers |
ProceedsFromCustomers
|
$43.37B | USD | 1 Quarter |
| Cash paid for inventory and prescriptions dispensed by retail network pharmacies |
PaymentsToSuppliers
|
$36.18B | USD | 1 Quarter |
| Cash paid for inventory and prescriptions dispensed by retail network pharmacies |
PaymentsToSuppliers
|
$36.20B | USD | 1 Quarter |
| Cash paid to other suppliers and employees |
PaymentsToSuppliersAndEmployees
|
$4.27B | USD | 1 Quarter |
| Cash paid to other suppliers and employees |
PaymentsToSuppliersAndEmployees
|
$3.82B | USD | 1 Quarter |
| Interest received |
ProceedsFromInterestReceived
|
$50.00M | USD | 1 Quarter |
| Interest received |
ProceedsFromInterestReceived
|
$6.00M | USD | 1 Quarter |
| Interest paid |
InterestPaidNet
|
$328.00M | USD | 1 Quarter |
| Interest paid |
InterestPaidNet
|
$545.00M | USD | 1 Quarter |
| Income taxes paid |
IncomeTaxesPaidNet
|
$57.00M | USD | 1 Quarter |
| Income taxes paid |
IncomeTaxesPaidNet
|
$53.00M | USD | 1 Quarter |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$2.35B | USD | 1 Quarter |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$3.53B | USD | 1 Quarter |
| Purchases of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$457.00M | USD | 1 Quarter |
| Purchases of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$482.00M | USD | 1 Quarter |
| Proceeds from sale of property and equipment and other assets |
ProceedsFromSaleOfPropertyPlantAndEquipment
|
$5.00M | USD | 1 Quarter |
| Proceeds from sale of property and equipment and other assets |
ProceedsFromSaleOfPropertyPlantAndEquipment
|
$2.00M | USD | 1 Quarter |
| Acquisitions (net of cash acquired) and other investments |
PaymentsToAcquireBusinessesNetOfCashAcquired
|
$368.00M | USD | 1 Quarter |
| Acquisitions (net of cash acquired) and other investments |
PaymentsToAcquireBusinessesNetOfCashAcquired
|
$93.00M | USD | 1 Quarter |
| Purchase of available-for-sale investments |
PaymentsToAcquireShortTermInvestments
|
$18.00M | USD | 1 Quarter |
| Maturity of available-for-sale investments |
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
|
$10.00M | USD | 1 Quarter |
| Maturity of available-for-sale investments |
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
|
$8.00M | USD | 1 Quarter |
| Proceeds from sale of subsidiary |
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
|
$725.00M | USD | 1 Quarter |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-131.00M | USD | 1 Quarter |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-537.00M | USD | 1 Quarter |
| Decrease in short-term debt |
ProceedsFromRepaymentsOfShortTermDebt
|
$-106.00M | USD | 1 Quarter |
| Decrease in short-term debt |
ProceedsFromRepaymentsOfShortTermDebt
|
$-1.28B | USD | 1 Quarter |
| Proceeds from issuance of long-term debt |
ProceedsFromDebtNetOfIssuanceCosts
|
$39.38B | USD | 1 Quarter |
| Repayments of long-term debt |
RepaymentsOfLongTermDebt
|
$1.00M | USD | 1 Quarter |
| Derivative settlements |
PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
|
$-446.00M | USD | Point-in-time |
| Derivative settlements |
PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
|
$-446.00M | USD | 1 Quarter |
| Repurchase of common stock |
PaymentsForRepurchaseOfCommonStock
|
$3.62B | USD | 1 Quarter |
| Dividends paid |
PaymentsOfDividends
|
$508.00M | USD | 1 Quarter |
| Dividends paid |
PaymentsOfDividends
|
$516.00M | USD | 1 Quarter |
| Proceeds from exercise of stock options |
ProceedsFromStockOptionsExercised
|
$121.00M | USD | 1 Quarter |
| Proceeds from exercise of stock options |
ProceedsFromStockOptionsExercised
|
$107.00M | USD | 1 Quarter |
| Payments for taxes related to net share settlement of equity awards |
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
$11.00M | USD | 1 Quarter |
| Payments for taxes related to net share settlement of equity awards |
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
$4.00M | USD | 1 Quarter |
| Net cash provided by (used in) financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$38.14B | USD | 1 Quarter |
| Net cash provided by (used in) financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$-4.13B | USD | 1 Quarter |
| Net increase (decrease) in cash, cash equivalents and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$-1.14B | USD | 1 Quarter |
| Net increase (decrease) in cash, cash equivalents and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$40.36B | USD | 1 Quarter |
| Cash, cash equivalents and restricted cash at the beginning of the period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$3.52B | USD | Point-in-time |
| Cash, cash equivalents and restricted cash at the beginning of the period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$42.26B | USD | Point-in-time |
| Cash, cash equivalents and restricted cash at the beginning of the period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$2.38B | USD | Point-in-time |
| Cash, cash equivalents and restricted cash at the beginning of the period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$1.90B | USD | Point-in-time |
| Cash, cash equivalents and restricted cash at the end of the period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$3.52B | USD | Point-in-time |
| Cash, cash equivalents and restricted cash at the end of the period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$42.26B | USD | Point-in-time |
| Cash, cash equivalents and restricted cash at the end of the period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$2.38B | USD | Point-in-time |
| Cash, cash equivalents and restricted cash at the end of the period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$1.90B | USD | Point-in-time |
| Net income |
ProfitLoss
|
$998.00M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$953.00M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$644.00M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$619.00M | USD | 1 Quarter |
| Stock-based compensation |
ShareBasedCompensation
|
$55.00M | USD | 1 Quarter |
| Stock-based compensation |
ShareBasedCompensation
|
$55.00M | USD | 1 Quarter |
| Deferred income taxes and other noncash items |
DeferredIncomeTaxExpenseBenefitAndOtherNonCashItems
|
$14.00M | USD | 1 Quarter |
| Deferred income taxes and other noncash items |
DeferredIncomeTaxExpenseBenefitAndOtherNonCashItems
|
$62.00M | USD | 1 Quarter |
| Accounts receivable, net |
IncreaseDecreaseInAccountsReceivable
|
$-48.00M | USD | 1 Quarter |
| Accounts receivable, net |
IncreaseDecreaseInAccountsReceivable
|
$857.00M | USD | 1 Quarter |
| Inventories |
IncreaseDecreaseInInventories
|
$-456.00M | USD | 1 Quarter |
| Inventories |
IncreaseDecreaseInInventories
|
$-464.00M | USD | 1 Quarter |
| Other current assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$74.00M | USD | 1 Quarter |
| Other current assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$-56.00M | USD | 1 Quarter |
| Other assets |
IncreaseDecreaseInOtherOperatingAssets
|
$113.00M | USD | 1 Quarter |
| Other assets |
IncreaseDecreaseInOtherOperatingAssets
|
$1.00M | USD | 1 Quarter |
| Accounts payable and claims and discounts payable |
IncreaseDecreaseInAccountsPayable
|
$-178.00M | USD | 1 Quarter |
| Accounts payable and claims and discounts payable |
IncreaseDecreaseInAccountsPayable
|
$-539.00M | USD | 1 Quarter |
| Accrued expenses |
IncreaseDecreaseInAccruedLiabilities
|
$1.23B | USD | 1 Quarter |
| Accrued expenses |
IncreaseDecreaseInAccruedLiabilities
|
$1.85B | USD | 1 Quarter |
| Other long-term liabilities |
IncreaseDecreaseInOtherOperatingLiabilities
|
$-7.00M | USD | 1 Quarter |
| Other long-term liabilities |
IncreaseDecreaseInOtherOperatingLiabilities
|
$154.00M | USD | 1 Quarter |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$2.35B | USD | 1 Quarter |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$3.53B | USD | 1 Quarter |
Comprehensive Income
13 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net income |
ProfitLoss
|
$998.00M | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$953.00M | USD | 1 Quarter |
| Foreign currency translation adjustments, net of tax |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$1.00M | USD | 1 Quarter |
| Foreign currency translation adjustments, net of tax |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$8.00M | USD | 1 Quarter |
| Net cash flow hedges, net of tax |
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
|
$1.00M | USD | 1 Quarter |
| Net cash flow hedges, net of tax |
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
|
$343.00M | USD | 1 Quarter |
| Total other comprehensive income |
OtherComprehensiveIncomeLossNetOfTax
|
$344.00M | USD | 1 Quarter |
| Total other comprehensive income |
OtherComprehensiveIncomeLossNetOfTax
|
$9.00M | USD | 1 Quarter |
| Comprehensive income |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$962.00M | USD | 1 Quarter |
| Comprehensive income |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$1.34B | USD | 1 Quarter |
| Comprehensive income attributable to noncontrolling interest |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
$1.00M | USD | 1 Quarter |
| Comprehensive income attributable to CVS Health |
ComprehensiveIncomeNetOfTax
|
$1.34B | USD | 1 Quarter |
| Comprehensive income attributable to CVS Health |
ComprehensiveIncomeNetOfTax
|
$961.00M | USD | 1 Quarter |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.